{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T17:50:46Z","timestamp":1648576246994},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.contraception.2012.11.007","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T21:01:56Z","timestamp":1355432516000},"page":"506-507","source":"Crossref","is-referenced-by-count":0,"title":["Response to the letter from Dr. Szarewski"],"prefix":"10.1016","volume":"87","author":[{"given":"Stephen","family":"Sidney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.11.007_bb0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.11.007_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1783\/147118910791749416","article-title":"Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case\u2013control study","volume":"36","author":"Dinger","year":"2010","journal-title":"J Fam Plan Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.11.007_bb0015","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case\u2013control study based on UK General Practice Research Database","volume":"342","author":"Parkin","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2012.11.007_bb0020","author":"Bayer Health Care Pharmaceuticals"},{"key":"10.1016\/j.contraception.2012.11.007_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jfprhc-2011-100260","article-title":"Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets","volume":"38","author":"Dinger","year":"2012","journal-title":"J Fam Plann Reprod Health Care"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412009778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412009778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T05:29:26Z","timestamp":1540013366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412009778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0010782412009778"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.11.007","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}